前列腺素是一组广泛存在于体内的自体活性物质,参与调节多种生理功能。胃肠道中的主要前列腺素包括前列腺素E(PGE)、前列腺素F(PGF)以及前列环素(PGI)。其中,胃部的前列腺素含量丰富,尤其在黏膜层中最为显著。
这类药物保护胃黏膜主要通过以下机制:
用于保护胃黏膜的主要前列腺素类药物包括喜克溃(米索前列醇)、恩前列素、利奥前列素、阿巴前列素、曲莫前列素和罗沙前列醇。其中,只有喜克溃已被正式应用于临床治疗。
喜克溃(米索前列醇)以片剂形式提供,每片含200微克。推荐剂量为每次口服200微克,每日4次(餐前及睡前服用)。疗程通常为4至8周。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
群博龙环已甲基碳酸酯 | Trenbolone cyclohexylmethylcarbonate | 23454-33-3 | C26H34O4 |
|
米索前列醇酸 | 7-[3-Hydroxy-2-(4-hydroxy-4-methyloct-1-enyl)-5-oxocyclopentyl]heptanoic acid | 112137-89-0 | C21H36O5 |
|
科里内酯 | (1S,5R,6S,7R)-7-benzoyloxy-6-hydroxymethyl-2-oxabicyclo[3.3.0]octan-3-one | 39746-00-4 | C15H16O5 |
|
硫前列酮 | Sulprostone | 60325-46-4 | C23H31NO7S |
|
甲烯前列素 | meteneprost | 61263-35-2 | C23H38O4 |
|
氯前列烯醇钠 | cloprostenol sodium | 62561-03-9 | C22H28ClO6*Na |
|
比马前列素 | bimatoprost | 155206-00-1 | C25H37NO4 |
|
曲沃前列素 | travoprost | 157283-68-6 | C26H35F3O6 |
|
曲前列尼尔 | treprostinil | 81846-19-7 | C23H34O5 |
|
拉坦前列素 | latanoprost | 130209-82-4 | C26H40O5 |
|
恩前列素 | enprostil | 73121-56-9 | C23H28O6 |
|
异丙基乌诺前列酮 | rescula | 120373-24-2 | C25H44O5 |
|
度他雄胺 | dutasteride | 164656-23-9 | C27H30F6N2O2 |
|
奥洛前列素 | methyl 7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S,5S)-3-hydroxy-5-methylnon-1-enyl]-5-oxocyclopentyl]-6-oxoheptanoate | 70667-26-4 | C23H38O6 |
|
地诺前列酮 | dinoprostone | 363-24-6 | C20H32O5 |
|
地诺前列素 | dinoprost | 551-11-1 | C20H34O5 |
|
吉美前列素 | gemeprost | 64318-79-2 | C23H38O5 |
|
卡巴他赛 | carbazitaxel | 183133-96-2 | C45H57NO14 |
|
卡前列素氨基丁三醇 | carboprost tromethamine | 58551-69-2 | C4H11NO3*C21H36O5 |
|
卡前列素 | Carboprost | 35700-23-3 | C21H36O5 |
|
前列地尔 | ALPROSTADIL | 745-65-3 | C20H34O5 |
|
依前列醇 | Epoprostenol | 35121-78-9 | C20H32O5 |
|
伊洛前列素苯甲酰甲基酯 | Iloprost phenacyl ester | 78919-13-8 | C30H38O5 |
|
伊洛前列素 | 5-{(E)-(1S,5S,6R,7R)-7-hydroxy-6-[(E)-(3S,4RS)-3-hydroxy-4-methyl-1-octen-6-ynyl]-bicyclo[3.3.0]octa-3-ylidene)-pentanoic acid | 78919-13-8 | C22H32O4 |
|
他氟前列素 | tafluprost | 209860-87-7 | C25H34F2O5 |
|
Prosta-2,13-dien-1-oicacid,11,15-dihydroxy-16,16-dimethyl-9-oxo-,methylester,(2E,11a,13E,15R)-(?脿)-(9CI) | Gemeprost | 64318-79-2 | C23H38O5 |
|
9-羟基-19,20-二去甲前列腺烷酸 | 7-(2-hexyl-5-hydroxy-cyclopentyl)-heptanoic acid | 56695-65-9 | C18H34O3 |
|
(5E,13E)-11,15-二羟基-9-氧代前列腺-5,13-二烯-1-酸 | (+/-)-prostaglandin E<sub>2</sub> | 363-24-6 | C20H32O5 |
|
(3aR,4S,5R,6aS)-(-)-六氢-4-(羟甲基)-2-氧代-2H-环戊并[b]呋喃-5-基 1,1'-联苯-4-甲酸酯 | (-)-Corey lactone 5-(4-phenylbenzoate) | 31752-99-5 | C21H20O5 |
|
(2E,11Α,13E,15S,17S)-11,15-二羟基-17,20-二甲基-9-氧代前列-2,13-二烯-1-酸(2E,11Α,13E,15S,17S)-11,15-DIHYDROXY-17,20-DIMETHYL-9-OXOPROSTA-2,13-DIEN-1-OICACID | limaprost | 74397-12-9 | C22H36O5 |
|
(+)-5-反式-氯前列醇 | D-Cloprostenol | 57968-81-7 | C22H29ClO6 |
|
—— | tromethamine prostaglandin | 58551-69-2 | C4H11NO3*C21H36O5 |
|
—— | Estrumate (TN) | 55028-72-3 | C22H28ClNaO6 |
|
—— | 5-[3,3a,4,5,6,6a-Hexahydro-5-hydroxy-4-(3-hydroxy-4-methyl-1-octen-6-ynyl)pentalen-2(1H)-ylidene]pentanoic acid | 78919-13-8 | C22H32O4 |
|
—— | 4-Diethylaminosalicylicacid | 99631-11-5 | C23H28O6 |
|
—— | 16-(3-chlorophenoxy)-17,18,19,20-tetranorprostaglandin F2 alpha | 40665-92-7 | C22H29ClO6 |
|
—— | epoprostenol sodium | 61849-14-7 | C20H31O5*Na |
|
—— | [(4R,5R)-4-(hydroxymethyl)-2-oxo-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-5-yl] 4-phenylbenzoate | 31752-99-5 | C21H20O5 |
|
—— | sodium;4-[(1R,2R,3aS,8bS)-2-hydroxy-1-[(3S)-3-hydroxy-4-methyloct-1-en-6-ynyl]-2,3,3a,8b-tetrahydro-1H-cyclopenta[b][1]benzofuran-5-yl]butanoate | 88475-69-8 | C24H29O5*Na |
|
—— | Dtxcid0028955 | 60325-46-4 | C23H31NO7S |
|
—— | Prostaglandin I2; Prostacyclin | 61849-14-7 | C20H31NaO5 |
|
—— | sodium;4-[(2R,3aS,8bS)-2-hydroxy-1-[(E,3S)-3-hydroxy-4-methyloct-1-en-6-ynyl]-2,3,3a,8b-tetrahydro-1H-cyclopenta[b][1]benzofuran-5-yl]butanoate | 88475-69-8 | C24H29NaO5 |
|
—— | (3aR-(3aalpha,4alpha,5beta,6aalpha))-Hexahydro-4-(hydroxymethyl)-2-oxo-2H-cyclopenta(b)furan-5-yl benzoate | 39746-00-4 | C15H16O5 |
|
—— | ICI 80996 sodium salt | 55028-72-3 | C22H28ClNaO6 |
|
—— | 15(S)-15-methyl-PGF2alpha | 58551-69-2 | C21H36O5 |
|
—— | beraprost sodium | 88475-69-8 | C24H29O5*Na |
|
—— | (+/-)-15-Deoxy-[16RS]-16-hydroxy-16-methylprostaglandin E1 | 112137-89-0 | C21H36O5 |
|
—— | Sodium 4-(2-hydroxy-1-(3-hydroxy-4-methyloct-1-en-6-yn-1-yl)-2,3,3a,8b-tetrahydro-1H-cyclopenta[b]benzofuran-5-yl)butanoate | 88475-69-8 | C24H29NaO5 |
|
—— | (Z)-7-((1R,2R,3R)-3-hydroxy-2-((R,E)-3-hydroxy-4-phenoxybut-1-enyl)-5-oxocyclopentyl)-N-(methylsulfonyl)hept-5-enamide | 60325-46-4 | C23H31NO7S |
|
—— | 5-[(3aS,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxy-4-methyloct-1-en-6-ynyl]-3,3a,4,5,6,6a-hexahydro-1H-pentalen-2-ylidene]pentanoic acid | 78919-13-8 | C22H32O4 |
|